… , is the use of the dual bronchodilation, which is a treatment that … (LAMA) with a long-acting
β 2 -agonist (LABA), rather than a … with dual bronchodilation when they are already taking a β-…

… the role of triple therapy containing a long-acting β-agonist (LABA), a long-acting muscarinic
… population, supporting the role of dual bronchodilation therapy for the treatment of COPD. …

… These drugs include β 2-adrenergic agonists and antago… on the high density of β 2-adrenergic
receptors (β 2-ARs) … effective bronchodilators are long-acting β 2adrenergic agonists (…

… The concept of dual bronchodilation can currently be achieved with a … dual-acting
bronchodilator treatments for COPD, muscarinic receptor antagonist and β 2 -adrenoceptor agonist (…

… Dual bronchodilation therapy is the cornerstone for the treatment of chronic obstructive …
Combining a long-acting β 2 adrenoceptor (β 2 -AR) agonist (LABA) with a long-acting …

… The wide availability of long-acting muscarinic antagonist (LAMA)/long-acting β2-agonist
(… In the meanwhile, we believe it is only proper to consider that dual bronchodilation is better …

… Dual bronchodilation with a long-acting β 2 -agonist and long-acting muscarinic antagonist
may be more effective treatment for some of these patients, with the aim of improving …

… Several fixed-dose combinations (FDCs) of long-acting bronchodilators (a long-acting
muscarinic antagonist [LAMA] plus a long-acting β 2 -agonist [LABA]) are available for the …

… ) and a long-acting β 2 -agonist (LABA) in a … double bronchodilation for the treatment of
COPD, with a specific focus on its efficacy versus placebo and/or monotherapy bronchodilation…

… In keeping with this paradox, we have found that cells expressing M 3 and β 2 receptors (but
not M 2 and β 2 receptors) show enhanced potency to muscarinic agonists compared to …